Yale New Haven Hospital

Anita Chandrasena, MD, Assumes New Role as Chief Medical Officer at MarinHealth Medical Center

Retrieved on: 
星期四, 一月 11, 2024

MarinHealth has named Anita Chandrasena, MD, Chief Medical Officer (CMO).

Key Points: 
  • MarinHealth has named Anita Chandrasena, MD, Chief Medical Officer (CMO).
  • She has been instrumental in advancing clinical quality, safety, and outcomes,” said MarinHealth Chief Executive Officer David Klein, MD.
  • Prior to this, she served as Physician Executive for the Bay Area and Chief Medical Officer at Sequoia Hospital.
  • “MarinHealth has earned a strong reputation for providing high-quality care, and I am honored to join the team,” Chandrasena said.

AI-Driven Study Redefines Right Heart Health Assessment With Novel Predictive Model

Retrieved on: 
星期四, 一月 4, 2024

NEW YORK, Jan. 4, 2024 /PRNewswire-PRWeb/ -- Departure from traditional methods marks a significant advance in evaluating heart health, paving the way for more innovative tools and improved patient outcomes

Key Points: 
  • "This novel method could expedite the identification of heart problems, especially in the right ventricle, and potentially lead to earlier and more effective treatment.
  • It holds particular importance for patients with congenital heart disease, who often face issues in the right ventricle."
  • "Our findings mark a significant leap forward in right heart health assessment, offering a glimpse into a future where AI plays a pivotal role in early and accurate diagnosis.
  • This study was supported by the National Heart, Lung, and Blood Institute, National Institutes of Health (R01HL155915), and National Center for Advancing Translational Sciences, National Institutes of Health (CTSA grant UL1TR004419).

Harvey J. Berger, M.D. Joins Kojin Therapeutics as Chairman, President, and Chief Executive Officer

Retrieved on: 
星期三, 一月 3, 2024

Kojin Therapeutics, Inc., a pioneer in cell-state and ferroptosis biology and cutting-edge drug discovery, today announced the appointment of Harvey J. Berger, M.D.

Key Points: 
  • Kojin Therapeutics, Inc., a pioneer in cell-state and ferroptosis biology and cutting-edge drug discovery, today announced the appointment of Harvey J. Berger, M.D.
  • as its new chairman, president, and chief executive officer.
  • He founded ARIAD Pharmaceuticals and led the company from a start-up to a fully integrated global oncology company.
  • Kojin co-founder Professor Stuart Schreiber stated, “We are thrilled to welcome Dr. Berger, a long-time colleague and collaborator, as Kojin’s new chief executive.

Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer

Retrieved on: 
星期一, 十二月 4, 2023

“We are thrilled to welcome Tanya and Jen to our executive team,” said Lonnie Moulder, Founder and Chief Executive Officer of Zenas BioPharma.

Key Points: 
  • “We are thrilled to welcome Tanya and Jen to our executive team,” said Lonnie Moulder, Founder and Chief Executive Officer of Zenas BioPharma.
  • “Tanya is a deeply experienced physician-scientist leader and Jen is a seasoned healthcare finance and corporate development leader.
  • Prior to joining Zenas, Ms. Fox served as Chief Financial Officer at Nuvation Bio, a publicly traded biotechnology company.
  • Prior to joining Zenas, she served as Chief Development Officer and Head of Translational Medicine at Biohaven, a publicly traded biopharmaceutical company.

Four Life Sciences Companies Announce Expansions in Connecticut

Retrieved on: 
星期二, 十二月 19, 2023

NEW HAVEN, Conn., Dec. 19, 2023 /PRNewswire/ -- AdvanceCT announced today that four life sciences companies are expanding their operations in Connecticut, including MannKind Corporation, Millstone Medical (formerly MycoScience), ReST Therapeutics, and Revalia Bio.

Key Points: 
  • Connecticut's Life Sciences Industry Booms as Four Companies Announce Expansions, with One Choosing Connecticut for U.S. Market Entry
    NEW HAVEN, Conn., Dec. 19, 2023 /PRNewswire/ -- AdvanceCT announced today that four life sciences companies are expanding their operations in Connecticut, including MannKind Corporation, Millstone Medical (formerly MycoScience), ReST Therapeutics, and Revalia Bio.
  • The $10 million investment in the expanded facility, which is expected to be operational in Q2 2024 and includes a cleanroom, will allow Millstone to offer a variety of new services to life sciences companies in Connecticut.
  • "Connecticut's life sciences industry has boomed in recent years," said John Bourdeaux, President and CEO of AdvanceCT.
  • "Our state's successes in the life sciences field are thanks in no small part to higher education partners such as Yale University and UConn," said Tim Miller, Senior Director of Business Development, Life Sciences at AdvanceCT.

SpinTech MRI and Yale New Haven Hospital to Examine Impact of STAGE on MRI Brain Exam Times, Backlogs, Workflows and Outcomes in Routine Clinical Use

Retrieved on: 
星期一, 十一月 27, 2023

BINGHAM FARMS, Mich., Nov. 27, 2023 /PRNewswire-PRWeb/ -- SpinTech MRI, creators of the STAGE™ (STrategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, today announced that Yale New Haven Hospital and YNHH Center for Health Care Innovation is conducting an in-depth analysis of the operational and clinical impacts of using STAGE for routine neuroimaging exams.

Key Points: 
  • Collaboration will assess operational and clinical impacts of STAGE through an analysis of neuroimaging efficiency, reporting workflows and clinical outcomes in actual cases.
  • It will examine the impact of STAGE adoption on efficiency, exam duration, image quality, radiology reading and reporting workflows, scanner throughput, imaging backlogs, sedation rates, patient experiences and return on investment.
  • The software quickly integrates with existing PACS and 1.5T and 3T scanners and requires no changes to reading and reporting workflows.
  • Testing at a busy U.S. health system in 2022 showed that multi-contrast scans using STAGE averaged 30% faster than conventional protocols.

Dr. Laura M. Tiedemann, Esteemed Oculoplastics Surgeon, Joins OCLI Vision's Growing Team

Retrieved on: 
星期五, 九月 29, 2023

GARDEN CITY, N.Y., Sept. 29, 2023 /PRNewswire-PRWeb/ -- OCLI Vision is proud to welcome Laura M. Tiedemann, MD, to their esteemed team of ophthalmologists. Dr. Tiedemann is a highly skilled and compassionate oculoplastics surgeon who brings her extensive expertise and dedication to patient care to the OCLI family. "As a New Jersey native, I am excited to join OCLI Vision and return to the tri-state area," Dr. Tiedemann shared. "Providing exceptional care to my patients has always been a passion of mine, and I am eager to make a meaningful impact on the eye health of my community."

Key Points: 
  • Esteemed oculoplastics surgeon Dr. Laura M. Tiedemann has joined OCLI Vision, specializing in minimally invasive cosmetic and reconstructive eye treatments.
  • GARDEN CITY, N.Y., Sept. 29, 2023 /PRNewswire-PRWeb/ -- OCLI Vision is proud to welcome Laura M. Tiedemann, MD, to their esteemed team of ophthalmologists.
  • Dr. Tiedemann is a highly skilled and compassionate oculoplastics surgeon who brings her extensive expertise and dedication to patient care to the OCLI family.
  • "As a New Jersey native, I am excited to join OCLI Vision and return to the tri-state area," Dr. Tiedemann shared.

Emerging Markets Report: Smart Minds, Smart Money

Retrieved on: 
星期三, 九月 27, 2023

ORLANDO, Fla, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Health care is always changing, evolving, endeavoring to be better for the patient and to be more profitable for the providers. In a perfect world, these separate needs align.

Key Points: 
  • Let’s start with the recognition that the health care experience for many Americans is wholly unsatisfying.
  • And the reality is that many patients are willing to pay a premium for better, more efficient care.
  • Too often we see great ideas sold as earners that are still in a nascent, beta, or concept state especially in white-hot markets like A.I.
  • But right now we wanted to make a first introduction to a Company full of smart minds looking to put smart money into one of the deepest verticals on the planet.

Black Diamond Therapeutics Announces CEO Transition

Retrieved on: 
星期一, 九月 18, 2023

CAMBRIDGE, Mass. and NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing therapies that target families of oncogenic mutations in patients with genetically defined cancers, announced that current Chairman of the Board, Mark Velleca, M.D., Ph.D., has been appointed as Chief Executive Officer (CEO) effective immediately. Dr. Velleca succeeds Company CEO and co-founder, David M. Epstein, Ph.D., who has stepped down and will continue to serve on the Board of Directors of the Company.

Key Points: 
  • and NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing therapies that target families of oncogenic mutations in patients with genetically defined cancers, announced that current Chairman of the Board, Mark Velleca, M.D., Ph.D., has been appointed as Chief Executive Officer (CEO) effective immediately.
  • Dr. Velleca succeeds Company CEO and co-founder, David M. Epstein, Ph.D., who has stepped down and will continue to serve on the Board of Directors of the Company.
  • Prior to joining the Black Diamond Board, Dr. Velleca served as CEO of G1 Therapeutics, Inc. (Nasdaq: GTHX).
  • Most recently, Dr. Velleca was CEO of StrideBio, a gene therapy company, and a Venture Partner at Hatteras Venture Partners.

FLORIDA SOUTHERN COLLEGE'S NURSES SHINE WITH REMARKABLE EMPLOYMENT SUCCESS

Retrieved on: 
星期二, 九月 12, 2023

LAKELAND, Fla., Sept. 12, 2023 /PRNewswire/ -- Florida Southern College (FSC)'s Ann Blanton Edwards School of Nursing and Health Sciences is celebrating an outstanding achievement as it reports a 100 percent employment rate for its May 2023 graduates.

Key Points: 
  • LAKELAND, Fla., Sept. 12, 2023 /PRNewswire/ -- Florida Southern College (FSC)'s Ann Blanton Edwards School of Nursing and Health Sciences is celebrating an outstanding achievement as it reports a 100 percent employment rate for its May 2023 graduates.
  • Florida Southern reports a 100% NCLEX pass and employment rate for its May 2023 nursing graduates.
  • "We are immensely proud of our graduates and their remarkable achievements," said Dr. Laly Joseph, Dean of the Ann Blanton Edwards School of Nursing and Health Sciences at Florida Southern College.
  • It also speaks volumes about the quality of the education and the clinical experiences they receive here at Florida Southern."